She once advised the president on aging issues. Now, she’s battling serious disability and depression.

The GoFundMe request jumped out at me as I was scrolling through posts on LinkedIn.

Tirzepatide Wins FDA Approval for Weight Loss

The FDA approved tirzepatide (Zepbound), the latest injectable for chronic weight management in adults, the agency announced on Wednesday. The combination glucagon-like peptide-1 (GLP-1) and

November 9, 2023

Study reveals age-related differences in amputation rates following PAD surgery

People in their 50s with severe peripheral artery disease or PAD may be more likely than people in their 80s to undergo leg amputation one

July 22, 2024

After cutting back on Vuity last fall, AbbVie culls a second-gen presbyopia eye drop

In 2021, AbbVie secured the first FDA approval for an eye drop for presbyopia, but in 2022 the drugmaker reduced sales and marketing on the

June 28, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.